World's Best Scientists 2026 revealed!
Lubka T. Roumenina

Lubka T. Roumenina

D-Index & Metrics

Immunology

D-Index
53
Citations
13770
World Ranking
3944
National Ranking
186

Lubka T. Roumenina publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lubka T. Roumenina sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 204 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lubka T. Roumenina D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lubka T. Roumenina sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lubka T. Roumenina is affiliated with Inserm in France. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant work in Immunology, Nephrology, Hematology, Molecular Biology, and Physiology.

The scientist's main research topics include the complement system in diseases, renal diseases and glomerulopathies, erythrocyte function and pathophysiology, blood groups and transfusion, hemoglobinopathies and related disorders, heme oxygenase-1 and carbon monoxide, and systemic lupus erythematosus research.

Lubka T. Roumenina has published papers in several frequent venues, including Immunobiology, Frontiers in Immunology, Nephrology Dialysis Transplantation, Blood, and the Journal of the American Society of Nephrology.

Some of their recent notable publications are:

  • B cells and cancer: To B or not to B?, 2020, The Journal of Experimental Medicine
  • C1q+ macrophages: passengers or drivers of cancer progression, 2022, Trends in Cancer
  • The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression, 2020, Genome Medicine
  • Complement System: Promoter or Suppressor of Cancer Progression?, 2020, Antibodies
  • C3-dependent effector functions of complement, 2022, Immunological Reviews

Their work has been conducted in collaboration with frequent co-authors such as Anne Grünenwald, Margot Revel, Idris Boudhabhay, Véronique Frémeaux-Bacchi, and Sophie Chauvet.

In addition to journal articles, Lubka T. Roumenina has contributed to academic books, including a publication with Springer Science+Business Media titled The Complement System published in 2021.

Best Publications

  • Complement System Part I - Molecular Mechanisms of Activation and Regulation

    Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Sarah Elizabeth Church;Sarah Elizabeth Church;Sarah Elizabeth Church;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina

  • Complement System Part II: Role in Immunity.

    Nicolas S. Merle;Remi Noe;Lise Halbwachs-Mecarelli;Veronique Fremeaux-Bacchi

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

    Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec

  • Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations

    Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée

  • Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

    Julien Zuber;Fadi Fakhouri;Lubka T. Roumenina;Chantal Loirat

  • Endothelium structure and function in kidney health and disease

    Noemie Jourde-Chiche;Noemie Jourde-Chiche;Fadi Fakhouri;Laetitia Dou;Jeremy Bellien

  • Context-dependent roles of complement in cancer

    Lubka T Roumenina;Marie V Daugan;Florent Petitprez;Catherine Sautès-Fridman

  • Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort

    Jane E. Salmon;Cara Heuser;Michael Triebwasser;M. Kathryn Liszewski

  • Complement factor H related proteins (CFHRs)

    Christine Skerka;Qian Chen;Veronique Fremeaux-Bacchi;Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina

  • Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

    Marie Frimat;Fanny Tabarin;Jordan D. Dimitrov;Jordan D. Dimitrov;Jordan D. Dimitrov;Caroline Poitou;Caroline Poitou

  • Complement alternative pathway acts as a positive feedback amplification of neutrophil activation.

    Laurent Camous;Lubka Roumenina;Sylvain Bigot;Soumeya Brachemi

  • Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

    Lubka T. Roumenina;Marie V. Daugan;Marie V. Daugan;Marie V. Daugan;Remi Noe;Remi Noe;Remi Noe;Florent Petitprez

  • C1q and its growing family

    Rohit Ghai;Patrick Waters;Lubka T. Roumenina;Mihaela Gadjeva

  • Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome

    Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina;Mathieu Jablonski;Mathieu Jablonski;Mathieu Jablonski;Christophe Hue;Christophe Hue;Christophe Hue;Jacques Blouin

  • Alternative complement pathway assessment in patients with atypical HUS.

    Lubka T. Roumenina;Chantal Loirat;Marie-Agnes Dragon-Durey;Lise Halbwachs-Mecarelli;Lise Halbwachs-Mecarelli

  • Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles

    Nicolas S. Merle;Nicolas S. Merle;Nicolas S. Merle;Anne Grunenwald;Anne Grunenwald;Anne Grunenwald;Helena Rajaratnam;Viviane Gnemmi

  • B cells and cancer: To B or not to B?

    Wolf Herman Fridman;Florent Petitprez;Maxime Meylan;Tom Wei-Wu Chen

  • Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains.

    Lubka T. Roumenina;Marieta M. Ruseva;Alexandra Zlatarova;Rohit Ghai

  • C1q+ macrophages: passengers or drivers of cancer progression

    Unknown

  • A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

    Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina;Marie Frimat;Marie Frimat;Elizabeth C. Miller;Francois Provot

Frequent Co-Authors

Marie-Agnès Dragon-Durey
Marie-Agnès Dragon-Durey Université Paris Cité
Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
Sébastien Lacroix-Desmazes
Sébastien Lacroix-Desmazes Sorbonne University
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Chantal Loirat
Chantal Loirat Grenoble Alpes University
Srini V. Kaveri
Srini V. Kaveri Centre national de la recherche scientifique, CNRS
Uday Kishore
Uday Kishore Brunel University London
Marina Noris
Marina Noris Mario Negri Institute for Pharmacological Research
John P. Atkinson
John P. Atkinson Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various allied health and nursing career pathways. Many students explore complementary programs that can enhance their expertise in patient care and research. For those interested in advancing quickly, accelerated nursing programs offer streamlined curriculums to enter the workforce sooner. These programs are especially beneficial for students seeking a fast-paced route into nursing.

Additionally, there are lpn programs easy to get into that provide foundational skills in nursing, making them accessible options for individuals aiming to build a healthcare career path related to Immunology. Similarly, exploring the easiest np programs to get into can lead to advanced practice roles that combine clinical expertise with immunological knowledge.

For professionals interested in mental health aspects within immunology and nursing, investigating pmhnp programs online with best clinical placement ensures access to quality training and practical experience. These diverse program options highlight the flexibility and range of career pathways available alongside Immunology studies.

Best Scientists Citing Lubka T. Roumenina

Trending Scientists

Recently Published Articles